The Eu Is Ready For Non-Biological Complex Medicinal Products

GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL（2016）

引用 20|浏览1

暂无评分

摘要

This paper describes the existing European Union legislation and scientific guidance to adequately assess the quality, safety and efficacy, as well as the lifecycle management, of the group of non-biological complex drug (NBCD) products, including nanomedicines such as liposomes, polymeric micelles, glatiramoids and iron-carbohydrate complexes.

查看译文

关键词

Complex pharmaceutical forms, EMA, nanomedicines, regulatory science

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要